Skip to content

LSD: all studies

Page 267 of 282: studies 2,661 to 2,670 of 2,815, newest first. Back to the LSD overview

Research

Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.

European Journal of Pharmacology June 2, 1994 D Marona-Lewicka, D E Nichols 32 citations

The behavioral effects of 5-methoxy-6-methyl-2-aminoindan (MMAI) were examined using the drug discrimination procedure and direct observation for classification of the characteristic syndrome induced by MMAI. The stimulus effects of MMAI were studied in 5 different groups of rats trained to discriminate MMAI (1.71 mg/kg; 8 microM/kg), MDMA (3,4-methylenedioxymethamphetamine; 1.75 mg/kg; 7.6...

Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives.

Pharmacology, Biochemistry, and Behavior March 1994 X Huang, D Marona-Lewicka, R C Pfaff et al.

Isopropyl (IPLA), N-methyl-N-isopropyl (MIPLA), N-ethyl-N-isopropyl (EIPLA), and N,N-diisopropyl (DIPLA) lysergamides were evaluated for lysergic acid diethylamide (LSD)-like activity. In rats trained to discriminate 0.08 mg/kg LSD tartrate from saline, each of the subject compounds completely substituted, with an ED50 two to three times larger than that of LSD except for DIPLA, which had an...

Some Effects of Group Drug Taking

Perspectives in biology and medicine March 1, 1994 Erwin Di Cyan

SOME EFFECTS OF GROUP DRUG TAKING ERWIN DI CYAN* The purpose of this paper is to discuss briefly some aspects of the differences between drug effects when drugs are used in groups as distinguished from their solitary use. The human organism responds to a variety of stimuli. Its response to signals may be physiological or psychological. The latter response includes recollections by (a) retrieval...

Psychedelic and Entactogenic Drugs in the Treatment of Depression

Journal of Psychoactive Drugs 1994 Thomas J. Riedlinger, June E. Riedlinger 39 citations

CNS deficiency of 5-hydroxytryptamine (serotonin) has been implicated as a biochemical basis in some forms of depression. Existing drug modalities for treating depression include some with serotonergic effects. Studies suggest that psychedelic drugs are also serotonergic. This may indicate a role for psychedelics in the treatment of depression. Such treatment has already been attempted using...

Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity.

European Journal of Pharmacology November 2, 1993 M D Schechter, T L Gordon 33 citations

Ibogaine is an alkaloid employed for its hallucinatory properties in West Central Africa which has been the subject of alleged efficacy as an aid in the interruption and treatment of chemical dependency. The major sources of the Schedule I agent are: Sigma Chemical Co., the National Institute on Drug Abuse and as NDA International Inc.'s Endabuse. The intent of the present study was to, for the...

Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats.

Psychopharmacology 1993 K M Krebs, Mark A. Geyer

Several reports have speculated that the tryptamine-derived drug alpha-ethyltryptamine (AET) may have effects similar to those of the amphetamine-derived drug 3,4-methylenedioxymethamphetamine (MDMA). Indeed, the US Drug Enforcement Administration has recently placed AET on the Schedule I list because of its putative similarity to MDMA. The Behavioral Pattern Monitor, which quantifies locomotor...

DOI: 10.1007/bf02245712 (opens in new tab) Animals Rats, sprague-dawley Tryptamines N-methyl-3,4-methylenedioxyamphetamine +7

Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA)

Behavioural Pharmacology October 1, 1992 Jonathan M. Broadbent, J. B. Appel, E. K. Michael et al. 18 citations

The isomers of 3,4-methylenedioxyamphetamine (MDA) functioned as discriminative stimuli in rats trained to discriminate either (-) MDA (1.25mg/kg) or (+) MDA (1.25mg/kg) from saline. Dose- and time-response curves indicated that drug lever selection occurred at doses of at least 1.00mg/kg of (-) MDA and 0.75mg/kg of (+) MDA and that drug-appropriate responding for both isomers was maintained...

DOI: 10.1097/00008877-199210000-00003 (opens in new tab) Stimulus control Discriminative model Stimulus psychology Artificial intelligence +1

Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors.

Neuropharmacology September 1992 Ursula Scheffel, John R. Lever, M Stathis et al.

The present study examined short- and long-term effects of MDMA (3,4-methylene-dioxymethamphetamine) on serotonin (5-HT2 and 5-HT1c) receptors in the brain of the rat. N1-Methyl-2-[125I]lysergic acid diethylamide ([125I]MIL) was used to label these receptors in vitro and in vivo. The usefulness of [125I]MIL for in vivo detection of changes in 5-HT2 receptors was confirmed in preliminary...

Therapeutic Effects of Hallucinogens

Anthropology of Consciousness October 1, 1991 Michael Winkelman

This paper reviews some of the evidence indicating that hallucinogens or psychedelic substances have therapeutic effects. The general character hallucinogen use in non‐ Western societies is briefly reviewed to present data about the characteristic beliefs and uses associated with these substances. Evidence for therapeutic effectiveness is addressed from several perspectives: the findings from...